WEBCAST | This SPAC Bamboozle $CLOV is on a Long Slide to Zero

02/09/21 10:04AM EST

"False teachers are leading retail investors astray," warns Hedgeye Health Policy analyst Emily Evans.

"(Mis)Leading Reddit users will not save Clover Health (CLOV) from what it is: a regional insurance company with a bad business model and a poor record of performance," she adds.

Join Emily below for a special webcast where she shines a light on Clover Health.

Among other things, she will discuss how:

  • CLOV has mischaracterized opportunities to expand TAM via a new federal program
  • Customer acquisition is fiercely competitive and their technology platform “Clover Assistant” is no special sauce
  • Its small size provides little purchasing power for health care services: a prerequisite for success
  • Customer satisfaction and patient outcomes put it at risk for regulatory intervention

CLICK HERE to access the associated slides

https://cdn.jwplayer.com/players/PhJCqsfh-x1Hp06Vr.js?sig=942aebd5346bda2715fb4135fc76c2b8&exp=1612987339

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.